Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04839796

Northeastern Taiwan Community Medicine Research Cohort

The cohort study on disease prevention and health promotion in the northeastern region of Taiwan is a trial dedicated to large-scale generational research in northeastern Taiwan beginning in the August of 2013. The program aims to develop a comprehensive and integrated approach to disease prevention and community health. The researcher's cohort organizes healthcare outreaches for participants over the age of 20 residing in 64 administrative areas in Keelung city and new Taipei city. The researcher's sessions include a comprehensive health examination, health-related questionnaires, and disease awareness seminars.

Biological samples, questionnaire information, and medical data obtained from researcher's participants are stored in researcher's core laboratory. Depersonalized data and samples are shared with partnering trials approved by the Chang Gung Memorial Hospital Institutional review board. The investigators are currently partnered with 18 clinical trials spanning across multiple disciplines such as urology, hepatology, metabolism, physical therapy, and psychology.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

The cohort study on disease prevention and health promotion in the northeastern region of Taiwan is a trial dedicated to large-scale generational research in northeastern Taiwan beginning in the August of 2013. The program aims to develop a comprehensive and integrated approach to disease prevention and community health. The researcher's cohort organizes healthcare outreaches for participants over the age in Keelung city and new Taipei city. The researcher's sessions include a comprehensive health examination, health-related questionnaires and disease awareness seminars.

Biological samples, questionnaire information, and medical data obtained from the researcher's participants are stored in the researcher's core laboratory. Depersonalized data and samples are shared with partnering trials approved by the Chang Gung Memorial Hospital Institutional review board. The investigators are currently partnered with 18 clinical trials spanning across multiple disciplines such as urology, hepatology, metabolism, physical therapy, and psychology.

The investigators are also a member of the national "Establish Multi-omics Database of Smart Healthcare for Obesity Therapeutics involving " joint project and the national "Remote Medical Monitoring System-Linking Healthcare Industrial Ecosystem-Taiwanese Novel Disease Monitoring Solution" initiative.

Introduction: This research is conducted in the form of community health care activities. Through regular community health household activities, community residents' awareness of health is improved, and various pathogenic factors are analyzed to strengthen health education, improve living habits, reduce risk factors, and promote the health of community residents.

Project purpose: In order to promote community fitness, The investigators will conduct long-term community medicine generation research. This research consists of a series of collaborative projects such as chronic kidney disease, chronic liver disease, metabolic syndrome, depression, dementia, obesity, exercise rehabilitation, etc.

In community health care activities, collect biological samples such as blood, urine, feces, etc., as well as questionnaire data. This project will link participants relevant health data to establish a database for the generation of Keelung Chang Gung community medicine research. These data will be provided for analysis of co-operative plans related to generations of research and long-term tracking of participants health.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Residing in Keelung city and new Taipei city.
  • Mobile health and mental health
  • Participating in healthcare outreaches

Exclusion criteria

  • Under 20 years old
  • Participant without judgment
  • Participant has HIV

Treatment and study plan

Primary outcomes

  1. Participant died during the observation period.

    Time frame: From 2013 Augus to Feb 2021

    Investigators keep in touch with participants and invite them to participate in healthcare outreaches every year.

  2. Dementia

    Time frame: From 2013 Augus to Feb 2021

    The AD8 dementia screening interview is used to detect the early signs of dementia. Using the items in the form to check whether participants have similar symptoms, so as to detect and treat them as soon as possible.

  3. Chronic Kidney Disease

    Time frame: From 2013 Augus to Feb 2021

    Chronic kidney disease is a type of kidney disease in which there is gradual loss of kidney function over a period of months to years.

  4. Liver cancer

    Time frame: From 2013 Augus to Feb 2021

    Participant suffers from liver cancer

Study contacts

Contact information is provided by the study sponsor or research team.

Rou Ling Cho, PHD

CONTACT

[email protected]

02-24329292 ext. 3391

Yu Chiau Shyu, PHD

CONTACT

[email protected]

02-24329292 ext. 3391

Sponsors and collaborators

Lead sponsor

Chang Gung Memorial Hospital

Other

Registry information

Official study title

A Cohort Study on Disease Prevention and Health Promotion in Northeastern Region of Taiwan

Acronym: NTCMRC

Important dates

Study start
2013
Primary completion
2043
Study completion
2043
First posted
Apr 9, 2021
Registry last updated
Apr 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.